http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3cddebeff2700da3959354e6fe5dd0b8
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Staudt |
| name | Louis M. Staudt Louis M Staudt |
| given-name | Louis M Louis M. |
| organization-name | 56Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD; Metabolism Branch, Center for Cancer Research, National Cancer Institute, 9000 Rockville Pike, Bethesda, Maryland 20892; Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD; From the Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD. Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 1 14Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Lymphoid Malignancies Branch, Center for Cancer Research and Metabolism Branch, National Cancer Institute, NIH, Bethesda, Maryland aMetabolism Branch, Division of Clinical Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 1Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland and Metabolism Branch, Center for Cancer Research, and Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; and Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; 1Metabolism Branch Metabolism Branch, NCI, Bethesda, MD; and Whitehead Institute for Biomedical Research, Cambridge, MA 02142, and Department of Biology, Massachusetts Institute ofTechnologv, Cambridge, MA 02139. Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Health Institutes, Bethesda, MD, USA, and Authors' Affiliations: 1Lymphoid Malignancies Branch, 2Laboratory of Pathology, 3Experimental Immunology Branch, Center for Cancer Research; 4Biometric Research Branch, DCTD, National Cancer Institute; 5Hematology Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland; 6Department of Pathology, University of Arizona, Tucson, Arizona; 7Oregon Health and Science University, Portland, Oregon; 8Cleveland Clinic Pathology and Laboratory Medicine Institute, Cleveland, Ohio; 9Department of Pathology, City of Hope National Medical Center, Duarte, California; 10Departments of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska; 11Department of Pathology, University of Würzburg, Würzburg; 12Department of Clinical Pathology, Robert-Bosch-Krankenhaus; 13Dr. Margarete Fischer-Bosch Institute for Clinical Pharmacology, Stuttgart, Germany; 14British Columbia Cancer Agency, Vancouver, British Columbia, Canada; 15Hospital Clinic, University of Barcelona, Barcelona, Spain; 16 4Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD David W. Scott, Pau Abrisqueta, Graham W. Slack, Anja Mottok, Diego Villa, Merrill Boyle, Fong Chun Chan, Christian Steidl, Joseph M. Connors, and Randy D. Gascoyne, BC Cancer Agency; Anja Mottok, Christian Steidl, and Randy D. Gascoyne, University of British Columbia, Vancouver, British Columbia; Jan Delabie, University of Toronto, Toronto, Ontario, Canada; Pau Abrisqueta, Vall d’Hebron University Hospital; Pedro Jares, Cristina Royo, Guillem Clot, Magda Pinyol, and Elias Campo, Universitat de Barcelona... National Cancer Institute, Bethesda, MD; and Center for Cancer Genomics, National Cancer Institute, National Institutes of Health, Bethesda, MD Metabolism Branch, Division of Clinical Sciences, National Cancer Institute, Bethesda, MD 20892, USA Center for Cancer Research, National Cancer Institute, National Institute of Health, Bethesda, MD; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 8Center for Cancer Research, Lymphoid Malignancies Branch, NCI, Bethesda, Maryland. 28Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 Metabolism Branch and Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; and Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892; Center for Cancer Research, National Cancer Institute, Bethesda, MD Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 2 Lymphoid Malignancies Branch, National Cancer Institute, NIH, Bethesda, MD 20892; Metabolism Branch, Center for Cancer Research National Cancer Institute, National Institutes of Health Bethesda Maryland Lymphoid Malignancies Branch, Center for Cancer Research and Biometric Research Program, Division of Cancer Diagnosis and Treatment, National Cancer Institute, National Institutes of Health, Rockville, MD; and Laboratory of Pathology 6 and 7; Metabolism Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892 6 and 7 Metabolism Branch, Center for Cancer Research, National Institutes of Health, Bethesda, MD; Metabolism Branch, National Cancer Institute, and Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892 From the University of Nebraska Medical Center, Omaha, NE; Rikshospitalet-Radiumhospitalet Medical Center, University of Oslo, Oslo, Norway; British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Robert-Bosch-Krankenhaus, Stuttgart; University of Würzburg, Würzburg; Charité–Universitätsmedizin Berlin, Berlin, Germany; Oregon Health and Science University, Portland, OR; University of Barcelona, Barcelona, Spain; and Division of Cancer Treatment and Diagnosis, Center for Cancer Research,... Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD; and Metabolism Branch, Division of Clinical Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland;; , Dept. of Biochemistry and Howard Hughes Medical Institute, Stanford University School of Medicine; National Cancer Institute, National Institutes of Health, Bethesda, MD Xin Huang, Bin Meng, Wenfeng Cao, and Kai Fu, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Tianjin; Chengfeng Bi, West China Hospital, West China School of Medicine of Sichuan University, Chengdu, China; Xin Huang, Bin Meng, Javeed Iqbal, Anamarija M. Perry, Wenfeng Cao, Lynette M. Smith, Chengfeng Bi, Chunsun Jiang, Timothy C. Greiner, Dennis D. Weisenburger, James O. Armitage, Julie M. Vose, Timothy W. McKeithan, Wing C. Chan, and Kai Fu,... Metabolism Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland 20892, USA. V. R. Iyer and D. T. Ross, Department of Biochemistry, Stanford University School of Medicine, Stanford CA 94305, USA. M. B. Eisen and D. Botstein, Department of Genetics, Stanford University School of Medicine, Stanford CA 94305, USA. G. Schuler and M. S. Boguski, National Center for Biotechnology Information, Bethesda MD 20894, USA. T. Moore and J. Hudson Jr., Research Genetics, Huntsville, AL 35801, USA. J. C. F. Lee, D. Lashkari, D. Shalon, Incyte Pharmaceuticals, Fremont, CA 94555, USA. J. M.... Metabolism Branch and National Cancer Institute, NIH, Bethesda, MD 20892, USA. Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD; 2Metabolism Branch, Center for Cancer Research, National Cancer Institute Bethesda, MD 20892 Metabolism Branch, Center for Cancer Research, National Cancer Institute; Bethesda, MD. Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick, Maryland, Molecular Target Screening Laboratory, SAIC-Frederick, Inc., Frederick, Maryland, Metabolism Branch, Center for Clinical Research, NCI, Bethesda, MD, and Natural Products Support Group, SAIC-Frederick, Inc., Frederick, Maryland Author affiliations appear at the end of this article. Authors' Affiliations: Departments of 1Pediatric Oncology, 2Cancer Biology, and 3Biostatistics and Computational Biology, Dana-Farber Cancer Institute; 4Division of Hematology/Oncology, Children's Hospital Boston, Boston; and 5Department of Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusetts; 6Division of Hematology and Medical Oncology, Knight Cancer Institute, and 7Division of Pediatric Hematology and Oncology, Department of Pediatrics, Oregon Health & Science University; 8Howard Hughes Medical Institute, Portland, Oregon; 9Division of Hematopoietic Stem Cell and Leukemia Research, Beckman Research Institute, City of Hope National Medical Center, Duarte; and 10Department of Medicine and Moores Cancer Center, University of California San Diego, La Jolla, California; 11Department of Pathology, Terry Fox Laboratory, BC Cancer Agency, Vancouver, British Columbia, Canada; 12Metabolism Branch, National Cancer Institute, Bethesda, Maryland; 13Human Oncology and Pathogenesis Progra ¶Metabolism Branch, National Cancer Institute, Bethesda, MD 20892; and Lymphoid Malignancies Branch Center for Cancer Research National Cancer Institute National Institutes of Health Bethesda MD USA Lymphoid Malignancies Branch, Center for Cancer Genomics, Center for Cancer Research 1Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 Authors' Affiliations: Departments of 1Pathology and Microbiology and 2Hematology/Oncology and 3College of Public Health, Department of Biostatistics, University of Nebraska Medical Center, Omaha, Nebraska; 4Center for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; 5Metabolism Branch and 6Laboratory of Pathology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland; 7Department of Pathology, University of Arizona, Tucson, Arizona; 8Department of Pathology, University of Würzburg, Würzburg; 9Department of Clinical Pathology, Robert Bosch Hospital and Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Baden-Württemberg, Germany; 10Department of Pathology, The Norwegian Radium Hospital, University of Oslo, Oslo, Norway; 11Hospital Clinic, University of Barcelona, Barcelona, Spain; 12Clinical Pathology, Oregon Health, Oregon; and 13Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio Lymphoid Malignancies Branch, National Cancer Institute, Bethesda, MD, USA From the Department of Clinical Pathology, Geneva University Hospital, Centre Medical Universitaire (CMU), Geneva, Switzerland; and the Metabolism Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD. Center for Cancer Research, Lymphoid Malignancies Branch, National Cancer Institute, Bethesda, MD; and Lymphoid Malignancies Branch and Departments of Medicine, Biochemistry, and Genetics, Division of Oncology and Howard Hughes Medical Institute, Stanford University Medical Center, Stanford, CA 94305-5306; Department of Pathology, University of Nebraska Medical Center, Omaha, NE 68198; and Metabolism Branch, Division of Clinical Sciences, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 Biometric Research Branch, Division of Cancer Treatment and Diagnosis and Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 From the Departments of Pathology and Microbiology, The Munroe-Meyer Institute for Genetics and Rehabilitation, Preventive and Social Medicine and Internal Medicine, University of Nebraska Medical Center, Omaha; Metabolism Branch, Division of Clinical Sciences, National Cancer Institute, National Institutes of Health, Bethesda, MD; and Departments of Pathology, Biochemistry, and Medicine, Stanford University Medical Center, Stanford, CA. Metabolism Branch, From the Department of Pathology and Hematology, Hospital Clinic, University of Barcelona; Cancer Epidemiology Service, Institut d’Investigació Biomedica de Bellvitge, Catalan Institute of Oncology and Laboratori d'Estadistica i Epidemiologia, Autonomous University of Barcelona; Department of Statistics, E.T.S.E.I.B. Polytechnics University of Barcelona, Barcelona, Spain; Department of Pathology, University of Würzburg, Würzburg, Germany; Biometric Research, Metabolism and Pathology Branch, National... Metabolism Branch, National Cancer Institute, NIH, Bethesda, MD; and A. L. Dent, A. L. Shaffer, X. Yu, L. M. Staudt, Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.; D. Allman, Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. Metabolism Branch, National Cancer Institute, Bethesda, Maryland 20892 Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892. Metabolism Branch, National Cancer Institute, Bethesda, MD; Metabolism Branch Center for Cancer Research, National Cancer Institute, NIH Bethesda MD USA Metabolism Branch, Center for Cancer Research National Cancer Institute Bethesda MD USA Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; Metabolism Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD; and From the Human Genetics Group and Genotyping Unit, Spanish National Cancer Centre; Department of Pathology, Hospital La Paz, Madrid; Department of Oncology, Hospital Son Dureta, Palma de Mallorca, Spain; and Lymphoid Malignancies Section and Laboratory of Pathology, National Cancer Institute, Bethesda, MD Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 2Metabolism Branch, Center for Cancer Research, National Cancer Institute, and Authors' Affiliations: 1Department of Pathology, University of Arizona; 2High ThroughPut Genomics; 3Arizona Cancer Center, Tucson, Arizona; 4Metabolism Branch, National Institutes of Health, Bethesda, Maryland; 5Department of Pathology, University of Nebraska, Omaha, Nebraska; 6Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio; 7Oregon Health & Sciences University, Portland, Oregon; 8British Columbia Cancer Agency, Vancouver, British Columbia, Canada; 9Department of Pathology, University of Barcelona, Barcelona, Spain; 10Department of Pathology, University of Würzburg, Würzburg; 11Institute of Pathology, Robert-Bosch Hospital and Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany; and 12Department of Pathology, Norwegian Radium Hospital, Oslo, Norway 1Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Metabolism Branch, Center for Cancer Research, NCI, NIH, Bethesda, MD; 1Metabolism Branch, Center for Cancer Research, National Cancer Institute 1Metabolism Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland and Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD From the Lymphoid Malignancies Branch (R.S., D.W.H., J.D.P., J.Q.W., S.R., M.K., R.M.Y., A.L.S., D.J.H., W. Xiao, X.Y., Y.Y., H.Z., W. Xu, W.H.W., L.M.S.), the Biometric Research Program, Division of Cancer Diagnosis and Treatment (G.W.W.), and the Laboratory of Pathology, Center for Cancer Research (E.S.J., S.P.), National Cancer Institute, and the Office of Intramural Research, Center for Information Technology (C.A.J., X.L., B.Z., W.D.), National Institutes of Health, Bethesda, and the Cancer Research... From the Leukemia/Lymphoma Molecular Profiling Project, Departments of Pathology and Microbiology, Genetics, Internal Medicine, and Preventive and Societal Medicine, University of Nebraska Medical Center, Omaha, NE; Metabolism Branch and Laboratory of Pathology, Center for Cancer Research, and Biometrics Research Branch, Department of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD; Department of Pathology, University of Arizona, Tucson, AZ;... Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD; and 2Metabolism Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland Metabolism Branch, Center for Cancer Research, National Cancer Institute, Building 10, 4N114, 9000 Rockville Pike, Bethesda, MD, USA 3Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. David W. Scott, Anja Mottok, Daisuke Ennishi, Pedro Farinha, Susana Ben-Neriah, Robert Kridel, Garrett S. Barry, Christoffer Hother, Pau Abrisqueta, Merrill Boyle, Barbara Meissner, Adele Telenius, Kerry J. Savage, Laurie H. Sehn, Graham W. Slack, Christian Steidl, Joseph M. Connors, and Randy D. Gascoyne, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; George W. Wright and Louis M. Staudt, National Cancer Institute, Bethesda, MD; and Lisa M. Rimsza, University of Arizona, Tucson, AZ. Lymphoid Malignancy Branch, Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA Metabolism Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD; Metabolism Branch, Division of Cancer Treatment and Diagnosis, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA; Amnis Corporation, Seattle, WA 98121, USA.; Biometric Research Branch, Division of Cancer Treatment and Diagnosis, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.; Department of Pathology, University of Würzburg, 97080 Würzburg, Germany.; Department of Clinical Pathology, Robert-Bosch-Krankenhaus, 70376 Stuttgart, Germany. *Metabolism Branch, National Cancer Institute, Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD; Departments of Microbiology and Immunology, Biochemistry, Genetics, and Medicine, and Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA 94305; Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; and Veterans Affairs Palo Alto Health Care System, Palo Alto, CA 94304 Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; Comprehensive Cancer Center Mainfranken, Würzburg, Germany; †Metabolism Branch, Division of Clinical Sciences, National Cancer Institute, Bethesda, MD 20892 Authors' Affiliations: Departments of 1Pathology and Microbiology, 2Internal Medicine, and 3Biostatistics, University of Nebraska Medical Center, Omaha, Nebraska; 4Lymphoma Group, Molecular Pathology Program, Spanish National Cancer Center, Madrid, Spain; 5Nuffield Department of Clinical Laboratory Sciences, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom; 6Department of Pathology, Rikshospitalet-Radiumhospitalet Medical Center, University of Oslo, Oslo, Norway; 7Department of Pathology, Oregon Health and Science University, Portland, Oregon; 8Metabolism Branch and 9Laboratory of Pathology, Division of Cancer Treatment and Diagnosis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland; 10Department of Pathology, British Columbia Cancer Agency, Vancouver, BC, Canada; 11Institute of Pathology, University of Würzburg, Würzburg, Germany; 12Department of Clinical Pathology, Robert-Bosch-Krankenhaus, and Institute of Clinical Pharmacology, Stuttgart, Germany; 13Departmen Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 8 Metabolism Branch, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD; Metabolism Branch, National Cancer Institute, Bethesda, MD 20892, USA Metabolism Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892; 1Metabolism Branch, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892 Authors' Affiliations: 1Molecular Oncology Section, 2Oncogenomics Section, Pediatric Oncology Branch, 3Metabolism Branch, Center for Cancer Research, and 4Comparative Molecular Cytogenetics Core Facility, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 3Lymphoid Malignancies Branch, NCI, Bethesda, Maryland. Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Health Institutes, Bethesda, MD Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892, United States Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA From the Center for Data Intensive Science, University of Chicago, Chicago (R.L.G., A.P.H.); the Ontario Institute for Cancer Research, Toronto (V.F.); Weill Cornell Medicine, Cornell University, New York (H.E.V.); and the National Cancer Institute, Bethesda, MD (D.R.L., W.A.K., L.M.S.). Center for Cancer Research, National Cancer Institute, Bethesda, MD; and |
Incoming Links
Total number of triples: 406.